Summit Wealth & Retirement Planning’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-4,362
Closed -$235K – 113
2022
Q3
$235K Buy
+4,362
New +$224K 0.09% 97
2022
Q2
– Sell
-4,417
Closed -$293K – 114
2022
Q1
$293K Sell
4,417
-145
-3% -$9.92K 0.1% 85
2021
Q4
$456K Sell
4,562
-174
-4% -$18K 0.16% 65
2021
Q3
$592K Buy
4,736
+95
+2% +$11.3K 0.22% 55
2021
Q2
$576K Sell
4,641
-111
-2% -$14.9K 0.21% 59
2021
Q1
$725K Sell
4,752
-2,688
-36% -$406K 0.27% 57
2020
Q4
$959K Sell
7,440
-100
-1% -$11.5K 0.36% 50
2020
Q3
$843K Sell
7,540
-445
-6% -$40.7K 0.36% 49
2020
Q2
$648K Sell
7,985
-250
-3% -$20.1K 0.3% 62
2020
Q1
$573K Buy
8,235
+410
+5% +$31.5K 0.31% 63
2019
Q4
$611K Buy
+7,825
New +$564K 0.27% 73

Other funds holding GH

Summit Wealth & Retirement Planning's GH Position: Q4 2022 in Review

Summit Wealth & Retirement Planning sold out of Guardant Health (GH) in Q4 2022, closing a stake of 4,362 shares — an estimated $235K sold.

Summit Wealth & Retirement Planning first reported a position in GH in Q4 2019 and held it in 11 quarters. The position peaked at $959K in Q4 2020. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Summit Wealth & Retirement Planning reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Summit Wealth & Retirement Planning sold 4,362 Guardant Health shares in Q4 2022, an estimated $235K.
  • Summit Wealth & Retirement Planning first reported a position in Guardant Health in Q4 2019 and held it in 11 quarters.
  • Summit Wealth & Retirement Planning's Guardant Health position peaked at $959K in Q4 2020.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Summit Wealth & Retirement Planning's 13F filing for Q4 2022, filed 10 Feb 2023.